CHRU de Nancy, Service de Maladies Infectieuses et Tropicales, Nancy, France.
Karolinska Institutet, Department of Public Health Sciences, Global Health - Health Systems and Policy, Stockholm, Sweden.
J Antimicrob Chemother. 2018 Apr 1;73(4):1084-1090. doi: 10.1093/jac/dkx528.
To evaluate the current practice and the willingness to shorten the duration of antibiotic therapy among infection specialists.
Infection specialists giving at least weekly advice on antibiotic prescriptions were invited to participate in an online cross-sectional survey between September and December 2016. The questionnaire included 15 clinical vignettes corresponding to common clinical cases with favourable outcomes; part A asked about the antibiotic treatment duration they would usually advise to prescribers and part B asked about the shortest duration they were willing to recommend.
We included 866 participants, mostly clinical microbiologists (22.8%, 197/863) or infectious diseases specialists (58.7%, 507/863), members of an antibiotic stewardship team in 73% (624/854) of the cases, coming from 58 countries on all continents. Thirty-six percent of participants (271/749) already advised short durations of antibiotic therapy (compared with the literature) to prescribers for more than half of the vignettes and 47% (312/662) chose shorter durations in part B compared with part A for more than half of the vignettes. Twenty-two percent (192/861) of the participants declared that their regional/national guidelines expressed durations of antibiotic therapy for a specific clinical situation as a fixed duration as opposed to a range and in the multivariable analysis this was associated with respondents advising short durations for more than half of the vignettes (adjusted OR 1.5, P = 0.02).
The majority of infection specialists currently do not advise the shortest possible duration of antibiotic therapy to prescribers. Promoting short durations among these experts is urgently needed.
评估感染专家目前的实践情况以及缩短抗生素治疗疗程的意愿。
邀请每周至少提供一次抗生素处方建议的感染专家参加 2016 年 9 月至 12 月期间的在线横断面调查。问卷包括 15 个临床病例,这些病例对应着具有良好转归的常见临床情况;A 部分询问他们通常会向开方医生建议的抗生素治疗疗程,B 部分询问他们愿意推荐的最短疗程。
我们纳入了 866 名参与者,他们主要是临床微生物学家(22.8%,197/863)或传染病专家(58.7%,507/863),73%(624/854)的参与者来自于抗生素管理团队,他们来自所有大洲的 58 个国家。36%(271/749)的参与者已经向开方医生建议对超过一半的病例采用较短的抗生素治疗疗程(与文献相比),47%(312/662)的参与者在 B 部分选择的疗程比 A 部分更短,超过一半的病例选择了较短的疗程。22%(192/861)的参与者表示,他们所在地区/国家的指南将特定临床情况下的抗生素治疗疗程表述为固定持续时间,而不是范围,多变量分析显示,这与回答者建议对超过一半的病例采用较短疗程有关(调整后的 OR 1.5,P=0.02)。
大多数感染专家目前并未向开方医生建议采用最短的抗生素治疗疗程。迫切需要在这些专家中推广采用较短的疗程。